| DATE |
SPEAKER |
SEMINAR TITLE |
| September 15 |
Lance R. McMahon, Ph.D.
Pharmacology
UT HSC San Antonio
|
Cannabinoid dependence and withdrawal: Drug discrimination and other behavioral indices |
| September 22 |
Becky Cunningham, Ph.D.
Pharmacology & Neuroscience UNTHSC |
Androgen regulation of cell viability: Implications for Parkinson's disease |
| September 29 |
Ilya Bezprozvanny, Ph.D.
Physiology
UT Southwestern Medical Center |
Presenilins and neuronal calcium signaling: Implications for Alzeimer's Disease |
| October 6 |
Jeffrey S. Smith, Ph.D.
Biochemistry and Molecular Genetics
University of Virginia Health System |
Identification of longevity factors using a yeast model system
|
| October 13 |
Robin Mockett, Ph.D.
Biomedical Sciences
University of South Alabama |
Prospects for further life extension in long-lived Drosophila |
| October 20 |
Society for Neuroscience |
No Seminar |
| October 27 |
Anne M. Dorrance, Ph.D.
Pharmacology and Toxicology
Michigan State University |
Hypertension, inflammation and the cerebral vasculature |
| November 3 |
E. Christopher Muly, M.D., Ph.D.
Neuroscience
Emory University |
Dopamine D1 receptor subtypes: Association and segregation within neural circuitry |
| November 10 |
John H. Zhang, Ph.D.
Physiology and Pharmacology
Loma Linda University School of Medicine
|
HIF-1 responses after stroke |
| November 17 |
Louise McCullough, M.D., Ph.D.
Neurology and Neuroscience
University of Connecticut Health Center |
Sex differences in stroke |
| December 1 |
Jen Bizon, Ph.D.
Psychology
Texas A&M University |
TBA |
| December 8 |
Charles L. White, M.D.
Pathology
UT Southwestern Medical Center |
TBA |
